Advertisement

Is Diabetic Nephropathy Preventable?

  • Eli A. Friedman
Chapter
  • 79 Downloads
Part of the Developments in Nephrology book series (DINE, volume 9)

Abstract

In 1975 Goodman and Schung reported the incidence of diabetes mellitus in North America to be approximately 1.5% to 2.5% [1]. Depending on diagnostic criteria employed, an additional 3% of Americans (total 5% to 6%) are diabetic. The financial toll imposed by diabetes on the health-care system is enormous. About one-third of hospitalized patients on a medical service are diabetic. More than one-quarter of new dialysis and kidney-transplant patients are diabetic. The cost of diabetic care can be measured in terms of the macrovascular and microvascular complications resulting from long-term diabetes, especially nephropathy and retinopathy.

Keywords

Glomerular Filtration Rate Diabetic Nephropathy Glomerular Basement Membrane Continuous Subcutaneous Insulin Infusion Renal Plasma Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goodman MJ, Schung C. Diabetes mellitus: discrimination between single locus and multifactorial modes of inheritance. Clin Genet 8: 66–74, 1975.PubMedCrossRefGoogle Scholar
  2. 2.
    Mauer SM, Barbosa J, Vernier RL, et al. Development of diabetic vascular lesion in normal kidney transplanted into patients with diabetes mellitus. N Eng J Med 295: 916–920, 1976.CrossRefGoogle Scholar
  3. 3.
    Abouna GM, Al-Adnani MS, Kremer GD, Kumar SA, Daddah SK, Kusma G. Reversal of diabetic nephropathy in human kidneys after transplantation into non-diabetic recipients. Lancet 2: 1274–1276, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Eng J Med 311: 89–93, 1984.CrossRefGoogle Scholar
  5. 5.
    Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Eng J Med 310: 356–360, 1984.CrossRefGoogle Scholar
  6. 6.
    Friedman EA. Diabetic nephropathy: strategies in prevention and management. Kid Int 21: 780–791, 1982.CrossRefGoogle Scholar
  7. 7.
    Kimmelstiel P, Wilson C. Intercapillary lesions in glomeruli of kidney. Am J Pathol 12: 83–105, 1936.PubMedGoogle Scholar
  8. 8.
    Ainsworth SK, Hirsh HZ, Brackett NC, et al. Diabetic glomerulonephropathy, histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Human Pathol 13: 470–478, 1982.CrossRefGoogle Scholar
  9. 9.
    Mauer SM, Steffes MW, Brown DM. The kidney in diabetes. Am J Med 70: 603–612, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Mauer SM, Michael AF, Fish AJ, et al. Spontaneous immunoglobulin and complement deposition in glomeruli of diabetic rats. Lab Invest 27: 488–494, 1972.PubMedGoogle Scholar
  11. 11.
    Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712, 1973.PubMedGoogle Scholar
  12. 12.
    McMillan D. Renal vascular changes in diabetes and their predicted effects. Endocrinol 97 (Suppl. 242): 26–28, 1981.Google Scholar
  13. 13.
    Viberti GC. Early functional and morphological changes in diabetic nephropathy. Clinical nephrology 12: 47–53, 1979.PubMedGoogle Scholar
  14. 14.
    Seyer-Hansen K. Renal hypertrophy in streptozotocin—diabetic rats. Clin Sci Mol Med 51: 551–555, 1976.Google Scholar
  15. 15.
    Seyer-Hansen K, Hansen J, Gundersen HJG. Renal hypertrophy in experimental diabetes: a morphometric metric study. Diabetologia 18: 501–505, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Christiansen JS, Gammelgaard J, Frandsen M, et al. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin dependent diabetics. Diabetologia 20: 451–456, 1981.PubMedGoogle Scholar
  17. 17.
    Fox M, Thier S, Rosenberg L, et al. Impaired renal tubular function induced by sugar infusion in man. J Clin Endocrinol Metab 24: 1318–1322, 1964.PubMedCrossRefGoogle Scholar
  18. 18.
    Brochner-Mortensen J. The glomerular filtration rate during moderate hyperglycemia in normal man. Acta Med Scand 194: 31–37, 1973.CrossRefGoogle Scholar
  19. 19.
    Ditzel J, Mortensen JB, Rodbro P. A combined disturbance in renal tubular handling of glucose and phosphate leads to increased glomerular filtration rate in diabetes mellitus: a new hypothesis. Acta Endocrinol 97 (Suppl. 242): 16–18, 1981.Google Scholar
  20. 20.
    Brenner BM, Hostetter TH, Olsen JL, et al. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol 97 (Suppl. 242): 7–10, 1981.Google Scholar
  21. 21.
    Viberti GC, Pickup JC, Phil D, et al. Effect of control of blood glucose on urinary excretion of albumin and B2 microglobulin in insulin-dependent diabetes. N Engl J Med 300: 638–41, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Stephen RL, Maddock RK Jr., Kablitz C, Maxwell JG, Jacobson SC, Petelenz TJ. Stabilization and improvement of renal function in diabetic nephropathy. Diabetic nephropathy 1: 8–13, 1982.Google Scholar
  23. 23.
    Keen H, Track ND, Sowry GSC. Arterial pressure in clinically apparent diabetics. Diabetes Metab 1: 159–178, 1975.Google Scholar
  24. 24.
    Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scan J Clin Lab Invest 36: 383–388, 1976.CrossRefGoogle Scholar
  25. 25.
    Parving HH, Andersen AR, Smidt U, et al. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy and the effect of antihypertensive treatment. Acta Endocrinol 97 (Suppl. 242): 39–40, 1981.Google Scholar
  26. 26.
    Christlieb AR, Kaldany A, D’Elia JA. Plasma renin activity and hypertension in diabetes mellitus. Diabetes 25: 969–974, 1976.PubMedCrossRefGoogle Scholar
  27. 27.
    Mogensen CE. Long-term antihypertensive treatment (over six years) inhibiting the progression of diabetic nephropathy. Acta Endocrinol 97 (Suppl. 242): 31–32, 1981.Google Scholar
  28. 28.
    Osterby R. Early phase in the development of diabetic glomerulopathy. Acta Med Scand 200 (Suppl. 574): 1–82, 1975.Google Scholar
  29. 29.
    Mauer SM, Brown DM, Steffes MW. Studies on the reversibility of kidney changes in experimental diabetes in the rat. Acta Endocrinol 97 (Suppl. 242): 29–30, 1981.Google Scholar
  30. 30.
    Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Glomerular basement membrane thickness. Diabetologia 16: 319–324, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment, the mesangium region. Diabetologia 17: 243–248, 1979.PubMedCrossRefGoogle Scholar
  32. 32.
    Mauer SM, Steffes MW, Sutherland DER, et al. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes 24: 280–285, 1974.Google Scholar
  33. 33.
    Barbosa J. Diabetes: the science and the art. Arch Int Med 143: 1118–1119, 1983.CrossRefGoogle Scholar
  34. 34.
    Sutherland DER, Goetz FC, Najarian JS. Review of world’s experience with pancreas and islet transplantation and results of intraperitoneal segmental pancreas transplantation from related and cadaver donors at Minnesota. Transplant Proc 13: 291–297, 1981.PubMedGoogle Scholar
  35. 35.
    Goetz FC. Evaluating the benefit of human islet transplantation. Diabetes 29 (Suppl. 1): 52–55, 1980.PubMedGoogle Scholar
  36. 36.
    Traeger J, Dubernard JM, Touraine JL, et al. Pancreatic transplantation in man: a new method of pancreas preparation and results on diabetes correction. Transplant Proc 11: 331–335, 1979.PubMedGoogle Scholar
  37. 37.
    Like AA, Rossini AA, Guberski DL, et al. Spontaneous diabetes mellitus—reversal and prevention in the BB/W rat with antiserum and rat lymphocyte. Science 206: 1421–1423, 1979.PubMedCrossRefGoogle Scholar
  38. 38.
    Laupacis A, Stiller CR, Gardell C, et al. Cyclosporine prevents diabetes in BB Wistar rats. Lancet 1 (8315): 10–12, 1983.PubMedCrossRefGoogle Scholar
  39. 39.
    Lee SM, Bressler R. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 30: 106–111, 1981.PubMedCrossRefGoogle Scholar
  40. 40.
    Rasch R. Studies on the prevention of glomerulopathy in diabetic rats. Acta Endocrinol 97 (Suppl 242): 43–44, 1981.Google Scholar
  41. 41.
    Mogensen CE, Steffes MW, Deckert TD, et al. Functional and morphological renal manifestations in diabetes mellitus. Diabetologia 21: 89–93, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Deckert T, Poulsen JE, Larsen M. Progression of diabetes with onset before the age of thirty-one, II factors influencing the prognosis. Diabetologia 14: 371–377, 1978.PubMedCrossRefGoogle Scholar
  43. 43.
    Steno Study Group. Effect of 6 months of strict metabolic control on eye and kidney function in insulin dependent diabetics with background retinopathy. Lancet 8264: 121–123, 1982.CrossRefGoogle Scholar
  44. 44.
    Lacy PE . The feasibility of human islet transplants. In: Diabetic Renal-Retinal Syndrome 3: Therapy, Friedman EA, L’Esperance FA Jr. (eds). New York: Grune & Stratton, 1985, in press.Google Scholar
  45. 45.
    Starzl TE, Iwatsuk S, Shaw BW Jr., Gordon RD. A resurgence of interest in whole pancreas transplantation. In: Diabetic Renal-Retinal Syndrome 3: Therapy, Friedman EA, L’Esperance FA Jr. (eds). New York: Grune and Stratton, 1985, in press.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • Eli A. Friedman

There are no affiliations available

Personalised recommendations